Valuation: HANDOK Inc.

Market Cap 109B 81.55M 72.53M 67.09M 61.22M 115M 7.74B 117M 808M 317M 4.03B 306M 299M 12.91B P/E 2024
-3.16x
P/E 2025 -69x
Enterprise Value 459B 344M 306M 283M 259M 487M 32.68B 496M 3.41B 1.34B 17.04B 1.29B 1.26B 54.52B EV / Sales 2024
0.95x
EV / Sales 2025 0.93x
Free-Float
52.22%
Yield 2024
1.66%
Yield 2025 -
1 day+2.57%
1 week-2.67%
Current month-0.71%
1 month-8.92%
3 months+3.08%
6 months-20.74%
Current year-25.27%
1 week 7,970
Extreme 7970
8,600
1 month 7,970
Extreme 7970
9,360
Current year 6,460
Extreme 6460
11,820
1 year 6,460
Extreme 6460
12,150
3 years 6,460
Extreme 6460
20,300
5 years 6,460
Extreme 6460
24,800
10 years 6,460
Extreme 6460
44,750
Manager TitleAgeSince
Chief Executive Officer 69 -
Chief Executive Officer 68 1995-12-31
Director of Finance/CFO 58 -
Director TitleAgeSince
Chairman 68 1995-12-31
Director/Board Member 69 -
Director/Board Member 58 -
Change 5-day change 1-year change 3-year change Capi.($)
+2.57%-2.67%-28.83%-33.25% 78.86M
+0.43%+7.48%+52.08%+106.34% 1,116B
+0.90%-0.36%+33.68%+62.93% 610B
+0.71%+4.77%+26.17%+92.90% 501B
+0.52%+2.51%+73.52%+40.32% 358B
-0.13%+7.51%+33.47%+48.68% 366B
-0.95%+5.93%+19.86%+42.48% 288B
-1.98%+4.66%-1.57%+13.41% 261B
-0.35%+6.15%+45.46%+52.23% 235B
-0.75%+6.18%+32.03%+101.15% 195B
Average +0.02%+4.84%+28.59%+52.72% 392.98B
Weighted average by Cap. -0.17%+4.93%+38.82%+72.15%

Financials

2024 2025
Net sales 507B 381M 338M 313M 286M 538M 36.11B 547M 3.77B 1.48B 18.83B 1.43B 1.4B 60.24B 535B 401M 357M 330M 301M 567M 38.08B 577M 3.98B 1.56B 19.86B 1.51B 1.47B 63.53B
Net income -52.56B -39.42M -35.06M -32.43M -29.59M -55.72M -3.74B -56.72M -391M -153M -1.95B -148M -145M -6.24B -2.15B -1.61M -1.44M -1.33M -1.21M -2.28M -153M -2.32M -16M -6.27M -79.89M -6.06M -5.93M -256M
Net Debt 317B 238M 212M 196M 179M 336M 22.58B 342M 2.36B 925M 11.78B 893M 874M 37.68B 351B 263M 234M 216M 197M 372M 24.94B 378M 2.6B 1.02B 13.01B 986M 965M 41.61B
Projected Income Statement - Annual - HANDOK Inc.
Logo HANDOK Inc.
Handok Inc is a Korea-based company primarily engaged in the manufacture and sale of pharmaceuticals. The Company operates its business through four segments. The Pharmaceutical segment mainly manufactures and sells prescription and over-the-counter drugs, including treatments for diabetes, hypertension, kidney diseases, respiratory diseases, central nervous system disorders, rare diseases, as well as anticancer drugs. The Medical Device segment mainly sells medical devices and diagnostic reagents. The Contract Manufacturing segment mainly provides contract manufacturing and quality control services for pharmaceuticals. The Real Estate Leasing segment mainly engages in the real estate leasing business.
Employees
910
Date Price Change Volume
26-10-16 ₩8,370.00 +2.57% 1,751
26-10-15 ₩8,160.00 -1.81% 7,076
26-10-14 ₩8,310.00 +1.84% 4,885
26-10-13 ₩8,160.00 -1.57% 3,503
26-10-12 ₩8,290.00 -3.60% 2,311
  1. Stock Market
  2. Stocks
  3. A002390 Stock